Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Wayne B. Weisman J.D. CEO | NASDAQ (CM) Exchange | US75629F1093 ISIN |
US Country | 258 Employees | - Last Dividend | 22 Nov 2019 Last Split | 7 Mar 2014 IPO Date |
Societal CDMO, Inc., previously known as Recro Pharma, Inc., is a recognized contract development and manufacturing organization (CDMO) that focuses on the creation, production, and packaging of various therapeutic dosage forms, predominantly for small molecules. The corporation offers its extensive services both within the United States and on an international scale. Having undergone a name change in March 2022, Societal CDMO, Inc. traces its origins back to 2007 and has its headquarters situated in Exton, Pennsylvania. The company's expertise in navigating regulatory requirements, alongside their comprehensive end-to-end service offerings, positions them as a key partner in the pharmaceutical industry, from the early stages of drug development to final product release.